Amy Davis is the Senior Director leading the Oncology Clinical Development organization for Eli Lilly and Company. During her near 22 years at Eli Lilly, Amy has held numerous leadership positions that span therapeutic areas supporting clinical and integrated drug development, medical affairs, strategy and operations, and project/portfolio management. In addition to her leadership roles, Amy is noted as a Diversity and Inclusion champion and has been recognized for her strong people development. Amy also serves as Lilly’s representative and Executive Committee Representative to Springboard Enterprises. She is a Pharmacy graduate of Purdue University and practiced Pharmacy prior to joining Lilly.
As the global pandemic continues to impact new and ongoing trials in Oncology, trial leaders, sponsors and administrators are looking for lessons on what others are doing to survive 2021 and trial integrity, as well as the remote patient experience. In this case study from one such example, attendees will gain insight into value added best practices across the trial spectrum including: